Why Outset Medical Shares Are Up Today - Outset Medical (NASDAQ:OM)

Published on 6 May 2024 on Benzinga

Outset Medical, Inc. OM shares are trading higher Monday after the company announced that TabloCart with prefiltration received FDA clearance.

The Details:

Read the rest of the article

Start tracking your investments with Statfolio

Revenue: $28.7 million for Q3 2024, a 5% sequential growth but a 6% year-over-year decline. Produ...

GuruFocus.com · via Yahoo Finance 7 Nov 2024

Outset Medical Inc (NASDAQ:OM) is set to release its Q3 2024 earnings on Nov 6, 2024. The consens...

GuruFocus.com · via Yahoo Finance 5 Nov 2024

Overview of JPMorgan Chase & Co's Recent Trade On August 30, 2024, JPMorgan Chase & Co executed a...

GuruFocus.com · via Yahoo Finance 21 Sep 2024

Overview of the Recent Transaction On August 31, 2024, AMERIPRISE FINANCIAL INC (Trades, Portfoli...

GuruFocus.com · via Yahoo Finance 21 Sep 2024

It's shaping up to be a tough period for Outset Medical, Inc. (NASDAQ:OM), which a week ago relea...

Simply Wall St. via Yahoo Finance 12 May 2024

Revenue: Reported $28.2 million, down from $33.5 million in the prior year, falling short of esti...

GuruFocus.com via Yahoo Finance 10 May 2024

Outset Medical, Inc. (NASDAQ:OM) Q1 2024 Earnings Call Transcript May 8, 2024 Outset Medical, Inc...

Insider Monkey via Yahoo Finance 9 May 2024

Outset Medical, Inc. (OM) came out with a quarterly loss of $0.57 per share versus the Zacks Cons...

Zacks via Yahoo Finance 8 May 2024

Outset Medical, Inc. (NASDAQ:OM), a company focused on innovative medical technology, has receive...

Investing.com 6 May 2024

Outset Medical, Inc. OM shares are trading higher Monday after the company announced that TabloCa...

Benzinga 6 May 2024